Grace Khaner and Melissa A. Laudano, MD, share their thoughts on the potential for expanding the use of vibegron early in treatment for OAB.
Melissa A. Laudano, MD
Advertisement
Articles by Melissa A. Laudano, MD
"We found that the location that prescribers were registered in, as well as their fellowship training, was significantly associated with higher vibegron prescription rates,” says Grace Khaner.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
3
FDA grants tentative approval to generic enzalutamide tablets
4
Fred Saad, MD, highlights PSA end points from the phase 3 PSMAddition trial
5